中外医学研究2016，Vol.14Issue(17)：3-4,2.DOI:10.14033/j.cnki.cfmr.2016.17.002
Graves病固定剂量与个体化剂量131I治疗的临床研究
Clinical Study of 131I Treatment of Fixed Dose and Individual Dose for Graves Disease
卢健祥 1冯彩莲 1陈亮明 1袁卫娟 1刘惠强1
作者信息
- 1. 东莞市第五人民医院 广东 东莞 523905
- 折叠
摘要
Abstract
Objective:To study the clinical effect of 131I treatment for Graves disease of fixed dose and individual dose,and the incidence condition of complications.Method:From March 2014 to March 2015,300 cases with Graves in our hospital were selected,and they were divided them into the control group and the research group.The control group was treated with the fixed dose 131I treatment,while the study group was treated with individual dose 131I treatment. And then they were followed up for 6 months,the clinical efficacy and complications incidence rate of the two groups were compared.Result:After treatment, the total effective rate of the control group was 80.67%,while the research group was 79.33%,and the difference between the two groups showed no statistically significant(P>0.05).However,the incidence of hypothyroidism in the control group was 48.67%,while the research group was 33.33%,and the difference between the two groups was statistically significant(P<0.05).Conclusion:The clinical efficacy of the fixed dose and individual dose 131I treatment for Graves disease are very significant,but the individual dose treatment has a low incidence rate of hypothyroidism.Benefit from the higher security,the individual dose 131I treatment is worthy of clinical popularization and application.关键词
Graves病/固定剂量/个体化剂量/131IKey words
Graves disease/Fixed dose/Individual dose/131I分类
医药卫生引用本文复制引用
卢健祥,冯彩莲,陈亮明,袁卫娟,刘惠强..Graves病固定剂量与个体化剂量131I治疗的临床研究[J].中外医学研究,2016,14(17):3-4,2.
